Both in Pharmaceuticals
Zymeworks vs Septerna
Over the past year ZYME returned +70.4% and SEPN returned +146.0%; their daily moves had a correlation of 0.21.
ZYME +70.4% SEPN +146.0%Growth of $1, one year, split-adjusted
| Metric | ZYME | SEPN |
|---|---|---|
| Price | $30.94 | $47.88 |
| Market cap | $2.22B | $2.23B |
| Today | +2.69% | +9.57% |
| 1 month | +20.6% | +34.2% |
| 6 months | +12.1% | +93.8% |
| Year to date | +17.5% | +71.7% |
| 1 year | +63.8% | +138.8% |
| Revenue growth (YoY) | −90.6% | +22375.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −980.8% | −48.7% |
| P/E (TTM) | — | — |
| Price / sales | 59.9× | 22.6× |
| Net cash | $270.7M | $372.3M |
| Dividend yield | — | — |
| Volatility (60d) | 47.0% | 49.1% |
| Short % of float | 12.5% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).